No Data
AngioDynamics, Inc. (NASDAQ:ANGO) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?
AngioDynamics, Inc. (NASDAQ:ANGO) Held Back By Insufficient Growth Even After Shares Climb 26%
When Will AngioDynamics, Inc. (NASDAQ:ANGO) Breakeven?
AngioDynamics Price Target Cut to $13.00/Share From $18.00 by Canaccord Genuity
AngioDynamics Is Maintained at Buy by Canaccord Genuity
CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Cuts Target Price to $13